Зарубежные авторы (часть 4)
Karliner J., Boucjard R., Cault J. Hemodynamic effects of radiocontrast in man: a beat by beat analysis. — Brit. Heart. J., 1972, vol. 34, p. 347 — 355.
Katz A., Messineo F. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. — Circulat. Res., 1981, vol. 48, N 1, p. 1 — 16.
Killip Th. Unstable angina — an overview. — Herz, 1980, vol. 5, N 2, p. 72 — 78.
Kirk E., Sonnenblick E. Newer conceps in the pathophysiology of ischemie heart disease. — Amer. Heart J., 1982, vol. 103, N 4, pt. 2, p. 756 — 767.
Ktagmann S., Salve K, Camrini F. Hemodynamic effects of nifedipine in heart failure. — Brit. Heart. J., 1980, vol. 43, p. 440 — 446.
Kleine N. Radiokardiographische Funktionsdiagnostik. — Munch, med. Wschr., 1973, Bd 15, S. 2260 — 2264.
Kloner R., Braunwald E. Observation on experimental myocardial ischemia. — Cardiovasc. Res., 1980, vol. 14, N 7, p. 371 — 395.
Kloner R., Ganote C, Jennings R. The «noreflow» phenomen after temporary coronary occlusion in the dog. — J. clin. Invest., 1974, vol. 54, p. 1496 — 1508.
Kubicek W., Petterson R., Witson D. Impedance cardiography as a noninvasive method of monitoring cardiac function and other parameters of the cradio-vascular system. — Ann. N. Y. Acad. Sci., 1970, vol. 170, p. 724 — 732.
Lamener L., Houtragers J., Voermans L. A comparison study of atenolol and penbutalol in hypertensive patients. — Europ. Heart J., 1983, vol. 4, Suppl. D., p. 53 — 56.
Lang E. Der EinfluS von Understands — und Volumenbelastung auf die systolischen Kontraktionszeiten der rechtan und linken Herzens. — Arch. Kreisl. — Forsch., 1971, Bd 66, S. 1 — 52.
Longer G. Events of the cardiac sarcolemma localization and movement of contractile-dependent calcium. — Fed. Proc, 1976, vol. 35, p. 1274 — 1278.
Larbig D. Digitalis therapie der Herzinsuffizienz. Aktuelle aspekte. — Therapie-woche, 1981, Bd 31, N 5, S. 497 — 504.
Lekuen I., Anderssen K- Migration of 15 micron microspheres from infarcted 1976, vol. 36, p. 1 — 6.
Lekven I., Anderssen K. Migration of 15 micron microspheres from infarcted myocardium. — Cardiovasc. Res., 1980, vol. 14, N 5, p. 280 — 287.
Lenzi S., Cuccurullo F. Salient metabolic feature in the myocardial cell. — Pharmacol. Res. Commun., 1981, vol. 13, N 3, p. 251 — 263.
Lund-Johansen P. Central haemodynamic effect of beta-blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutalol, alprenolol, pindolol and bunitrolol. — Europ. Heart J., 1983, vol. 4, Suppl. D., p. 1 — 12.
Luomanmäki X., Heikkilä J. Duration of the phases of left ventricular mechanical systole in healthy men agen 45 to 64 years. — Ann. clin. Res., 1969, vol. 1, p. 156 — 164.
Lyon L., Nevius M. Alprenolol treatment in angina pectoris. — J.A.M.A., 1971, vol. 215, p. 1669 — 1675.
McCarthy J., Palmer F. Incidence and significance of ceronary artery calcification, — Brit. Heart J., 1974, vol. 36, N 5, p. 499 — 506.
McCord J., Roy R. The pathophysiology of superoxide: roles in inflammation and ischemia. — Canad. J. Physiol. Pharmacol, 1982, vol. 80, N 11, p. 1346 — 1352.
McHaffie D., Purcell H., Mitchell-Heggs P., Guz A. The clinical value of digoxis in patients with heart failure and sinus rhythm. — Quart. J. Med., 1978, vol. 188, p. 401 — 419.
Magnani В., Bracchetti D., Malini P. L. Indicationi e contrainidication al trattamento digitalico. — Atti Sci. ital. Cardiol., 1980, vol. 39, N 2, p. 59 — 70.
Manthey J., Dietz R., Leinberger H. et al. Vasodilator therapie in heart failure limited by activation of vasoconstrictor mechanisms. — Circulation, 1980, vol. 62, N 4, pt. 2, p. 259 — 262.
Marshall R., Parratt J. The early consequences of myocardial ischemia and their modification. — J. Physiol. (Paris), 1980, vol. 76, N 7, p. 699 — 715.
Maseri A., Chieri A., Chierchia S. Coronary artery soasm: demonstration definition, diagnosis and consequence. — Progr. cardiovasc. Dis., 1982, vol. 25, N 3, p. 169 — 192.
Maseri A., Seven S., De Nes M., L’Abbate A. «Variant» angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. — Amer. J. Cardiol., 1978, vol. 42, N 6, p. 1019 — 1035.
Mason D., Spann J., Zelis R. Alterations of hemodynamics and myocardial mechanics in patients with congestive heart failure. — Progr. cardiovasc. Dis., 1970, vol. 12, p. 507 — 516.
Mehta J., Conti C. Verapamil therapy for unstable angina pectoris: review of double-blind placebo controlled randomized clinical trails. — Amer. J. Cardiol., 1982, vol. 50, p. 919 — 922.
Mehta I., Mehta P. Role of blood platelets and prostaglandins in coronary artery disease. — Amer. J. Cardiol., 1981, vol. 48, N 2, p. 366 — 374.
Metha I., Peplne C, Day M. et al. Short-term efficacy of oral verapamil in rest angina. A double-blind placeb-controlled trial. — Amer. J. Med., 1981, vol. 71, p. 977 — 982.
Moncada S., Gryglewski R., Buuting S. et al. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable that inhibitis platelet aggregation. — Nature (London), 1976, vol. 263, p. 663 — 665.
Moneada S., Vane I. The role of prostacyclin in vascular tissue. — Fed. proa, 1979, vol. 38, N 1, p. 66 — 71.
«Коронарная и миокардиальная недостаточность»,
Л.И.Ольбинская, П.Ф.Литвицкий
